A 32-year-old Caucasian man was referred for refractory epilepsy and presumed AE. His symptoms began at 27 with confusion, vomiting, and amnesia thought to be in the setting of uremia. Subsequently, he represented with generalized tonic-clonic seizures. Due to MRI showing subtle hyperintensity in bilateral mesial temporal lobes, he was diagnosed as autoimmune encephalitis. Despite, serum and CSF autoimmune/paraneoplastic antibody panels being negative multiple times, he continued to be treated, as seronegative AE with multiple immunotherapies including high-dose steroids, monthly high-dose monthly IVIG, rituximab and mycophenolate mofetil. Notably, during our assessment, café au lait spots were observed, and the patient reported learning difficulties in childhood. Whole gene exome sequencing and mitochondrial analysis ultimately revealed a heterozygous variant (c.2509 T>C p.W837R) consistent with NF1. This suggested that his symptoms and refractory epilepsy were most likely primarily due to NF1. Consequently, immunosuppressive treatment was halted, and patient was referred to specialized clinics for multidisciplinary follow-up.